Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 12:24 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1849–1872 of 21,040 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: ONE Clear all

Conditions: Spinal Cord Injuries
Interventions: Epidural stimulation + Stand Training, Epidural stimulation + Step Training, Epidural stimulation + Bladder Capacity Training, Epidural stimulation + Bladder Voiding Efficiency Training; Combination Product
Lead sponsor: Claudia Angeli; Other
Eligibility: 18 Years to 65 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2029
U.S. locations: 1
States / cities: West Orange, New Jersey

Conditions: Atrial Fibrillation
Interventions: Metformin, Recommendations for lifestyle modification., AliveCor; Drug · Behavioral · Device
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 117 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Solid Tumors, GI Cancer
Interventions: CGX1321, Pembrolizumab, encorafenib, cetuximab; Drug
Lead sponsor: Curegenix Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2023
U.S. locations: 25
States / cities: Long Beach, California • Santa Rosa, California • Denver, Colorado + 21 more

Conditions: Edentulism, Tooth Loss
Interventions: dental implant; Device
Lead sponsor: CeraRoot SL; Industry
Eligibility: 18 Years and older
Enrollment: 652 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2030
U.S. locations: 1
States / cities: Boulder, Colorado

Conditions: Follicular Helper T-Cell Lymphoma, Peripheral T-Cell Lymphoma, Not Otherwise Specified
Interventions: Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Computed Tomography, Duvelisib, Positron Emission Tomography, Survey Administration; Procedure · Drug · Other
Lead sponsor: City of Hope Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Duarte, California

Conditions: Recurrent Cholecystitis, Cholecystitis, Symptomatic Gallbladder Disease, Biliary Colic
Interventions: ERCP with one stent placement, ERCP with two stent placement; Procedure
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 95 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Gorham Disease, Lymphatic Diseases, Lymphangiomatosis
Interventions: Dynamic Contrast Enhanced Magnetic Resonance Lymphangiography (DCMRL), Heavy Weighted T2 Imaging (T2W), Lymph Node Access; Other
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 2 Years to 80 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Osteoporosis
Interventions: Fructooligosaccharide; Dietary Supplement
Lead sponsor: Purdue University; Other
Eligibility: 10 Years to 12 Years · Female only
Enrollment: 26 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009
U.S. locations: 1
States / cities: West Lafayette, Indiana

Conditions: Sickle Cell Disease
Interventions: acupuncture; Other
Lead sponsor: Deepika Darbari; Other
Eligibility: 8 Years to 22 Years
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Breast Cancer
Interventions: Radiation Therapy, Capecitabine; Radiation · Drug
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2017
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Treatment-Resistant Hypertension
Interventions: Structured center-based lifestyle intervention, Standard education and physician advice; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 35 Years and older
Enrollment: 140 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Metastatic Cancer
Interventions: surgical procedure, radiation therapy, stereotactic radiosurgery; Procedure · Radiation
Lead sponsor: Radiation Therapy Oncology Group; Network
Eligibility: 18 Years and older
Enrollment: 333 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1996 – 2004
U.S. locations: 240
States / cities: Birmingham, Alabama • Huntsville, Alabama • Mobile, Alabama + 184 more

Conditions: Dry Eye, Meibomian Gland Dysfunction
Interventions: Varenicline 0.03Mg/Spray Nasal Soln; Drug
Lead sponsor: University of California, Berkeley; Other
Eligibility: 18 Years and older
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Berkeley, California

Conditions: Compliance, Chronic Pain
Interventions: acetazolamide, Quinine, Riboflavin; Drug
Lead sponsor: Georgetown University; Other
Eligibility: 18 Years to 50 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Age-Related Macular Degeneration
Interventions: Low glycemic Mediterranean diet behavioral modification; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 55 Years to 75 Years
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Obesity
Interventions: Small change approach to improve physical activity and diet, MOVE! Usual Care; Behavioral
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 18 Years and older
Enrollment: 481 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 2
States / cities: Ann Arbor, Michigan • Cleveland, Ohio

Conditions: Presbyopia
Interventions: Investigational contact lens, PureVision contact lens; Device
Lead sponsor: Bausch & Lomb Incorporated; Industry
Eligibility: 18 Years and older
Enrollment: 126 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Spinal Cord Injury
Interventions: Transcranial direct current stimulation; Device
Lead sponsor: Spaulding Rehabilitation Hospital; Other
Eligibility: 18 Years to 64 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Postoperative Nausea and Vomiting, Nausea and Vomiting, Postoperative
Interventions: GW597599; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 55 Years · Female only
Enrollment: 624 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2006
U.S. locations: 17
States / cities: Little Rock, Arkansas • Glendale, California • Laguna Hills, California + 13 more

Conditions: Cannabis Intoxication
Interventions: Cannabis, Pregnenolone 250 mg, Pregnenolone 500 mg, Placebo, Placebo brownie; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Acute Stroke
Interventions: SA controller, TA controller, SA controller early testing; Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Deafness
Interventions: Electrode-Neural Interface; Device
Lead sponsor: NYU Langone Health; Other
Eligibility: 2 Years to 90 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: IBS (Irritable Bowel Syndrome)
Interventions: Inulin, Low-fiber control breakfast shake, Atmo Gas-Sensing Capsule, CapScan Regional Fluid-Sampling Capsule; Dietary Supplement · Other · Device
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Stanford, California

Conditions: Hypotension, Orthostatic
Interventions: Midodrine hydrochloride, Placebo; Drug
Lead sponsor: Shire; Industry
Eligibility: 19 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2005
U.S. locations: 11
States / cities: Fort Wayne, Indiana • Boston, Massachusetts • Ann Arbor, Michigan + 8 more

Search by objective public record fields.

Locomotor and Bladder Function in Individuals With Acute Spinal Cord Injury

Metformin as an Adjunctive Therapy to Catheter Ablation in Atrial Fibrillation

CGX1321 in Subjects With Advanced Solid Tumors and CGX1321 With Pembrolizumab or Encorafenib + Cetuximab in Subjects With Advanced GI Tumors (Keynote 596)

5-Years PMCF Study of Ceramic Dental Implants One-piece Versus Two-piece.

Duvelisib Maintenance for the Treatment of Peripheral T-Cell Lymphomas

One vs. Two Stents for Gallbladder Disease

Imaging of Lymphatic Anomalies

Fructooligosaccharide and Calcium Absorption in Adolescent Girls

Acupuncture for Pain in Sickle Cell Disease

Xeloda (Capecitabine) and External Beam Radiation

Lifestyle Interventions in Treatment-Resistant Hypertension

Radiation Therapy With or Without Radiosurgery in Treating Patients With Brain Metastases

Ocular Surface Health and Tear Film Stability With a Nasal Spray Dry Eye Treatment

Evaluation of a Compliance Marker in Prescription Opioid Abusers With Chronic Pain

Feasibility Study of a Remote Behavioral Dietary Intervention in Patients With Early to Intermediate AMD: Glucose Lowering for Vision Extension

Coaching Veterans to Healthy Weights and Wellness

A Study to Evaluate the Feasibility of a High Add Multi Focal Contact Lens

Application of Transcranial Direct Current Stimulation (tDCS) in Patients With Chronic Pain After Spinal Cord Injury

Study Of An NK-1 Anti-Emetic Medication For The Prevention Of Post-Operative Nausea And Vomiting In Female Patients

Pregnenolone as a Treatment for Cannabis Intoxication

An Upper Extremity Exoskeleton to Target Unwanted Joint Synergies During Repetitive Training in Stroke Survivors

Investigating Auditory Processing in the Users of Auditory Brainstem and Cochlear Implants

High-Resolution Measurements of Diet-Microbiome Interactions

Study to Assess the Benefit of Midodrine in the Treatment of Patients With Neurogenic Orthostatic Hypotension